Why the study?
Does the Navitor THV system prevent adverse events and PVL in patients with aortic stenosis at high or extreme surgical risk?
Does the Navitor THV system prevent adverse events and PVL in patients with aortic stenosis at high or extreme surgical risk?
The Navitor THV system is safe and effective for treating aortic stenosis in patients at high or extreme surgical risk, with low rates of adverse events and paravalvular leak at 1 year.
Answers are grounded in this paper and cite their sources.
Should not yet change practice with Navitor THV; leaves open randomized confirmation in high-risk aortic stenosis.
The PORTICO NG Study demonstrates low rates of adverse events and PVL up to 1 year in patients at high or extreme surgical risk, confirming the safety and efficacy of the Navitor THV system.
No takes yet. Share an insight, caveat, or question.
Søndergaard et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: